Molecular modeling of human BAD, a pro-apoptotic Bcl-2 family member, integrating glycolysis and apoptosis

Protein and Peptide Letters

Volumn 17, Issue 2, 2010, Pages 206-220

  Yang, Jie ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Computational modeling; Protein protein interaction; Sequence alignment

Indexed keywords

AMINO ACID; BAD PROTEIN, HUMAN; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN 14 3 3; PROTEIN BAD; PROTEIN BCL X; PROTEIN BID;

AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; ARTICLE; BIOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; ENZYME ACTIVE SITE; GLYCOLYSIS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN DATABASE; PROTEIN DOMAIN; SEQUENCE ALIGNMENT; SURFACE PROPERTY;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CATALYTIC DOMAIN; COMPUTATIONAL BIOLOGY; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DATABASES, PROTEIN; GLYCOLYSIS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PHOSPHATASE 1; SEQUENCE ALIGNMENT; SURFACE PROPERTIES;

EID: 77949993427     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610790226003     Document Type: Article

References (59)

1. Ottilie, S.; Diaz, J.L.; Horne, W.; Chang, J.; Wang, Y.; Wilson, G.; Chang, S.; Weeks, S.; Fritz, L.C.; Oltersdorf, T. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J. Biol. Chem., 1997, 272(49), 30866-30872.
2. Petros, A.M.; Nettesheim, D.G.; Wang, Y.; Olejniczak, E.T.; Meadows, R.P.; Mack, J.; Swift, K.; Matayoshi, E.D.; Zhang, H.; Thompson, C.B.; Fesik, S.W. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci., 2000, 9, 2528-2534.
3. Danial, N.N.; Gramm, C.F.; Scorrano, L.; Zhang, C.Y.; Krauss, S.; Ranger, A.M.; Datta, S.R.; Greenberg, M.E.; Licklider, L.J.; Lowell, B.B.; Gygi, S.P.; Korsmeyer, S.J. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature, 2003, 424, 952-956.
4. Harada, H.; Becknell, B.; Wilm, M.; Mann, M.; Huang, L. J.-S.; Taylor, S.S.; Scott, J.D.; Korsmeyer, S.J. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell., 1999, 3, 413-422.
5. Wojtal, K.A.; Hoekstra, D.; van Ijzendoorn, S.C.D. Anchoring of Protein Kinase A-Regulatory Subunit II to Subapically Positioned Centrosomes Mediates Apical Bile Canalicular Lumen Development in Response to Oncostatin M but Not camp. Mol. Biol. Cell., 2007, 18, 2745-2754.
6. Song Q.; Khanna K.K.; Lu H.; Lavin M.F. Cloning and characterization of a human protein phosphatase 1-encoding cDNA. Gene, 1993, 129, 291-295.
7. Tanizawa Y.; Matsutani A.; Chiu K.C.; Permutt M.A. Human glucokinase gene: isolation, structural characterization, and identification of a microsatellite repeat polymorphism. Mol. Endocrinol., 1992, 6, 1070-1081.
8. Lockshin, R.A.; Zakeri, Z. Programmed cell death and apoptosis: origins of the theory. Nature Rev. Mol. Cell Biol., 2001, 2, 542-550.
9. Gross, A.; Yin, X.M.; Wang, K.; Wei, M.C.; Jockel, J.; Milliman, C.; Erdjument-Bromage, H.; Tempst, P.; Korsmeyer, S.J. Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death. J. Biol. Chem., 1999, 274(2), 1156-1163.
10. Qiu, J.; Whalen, M.J.; Lowenstein, P.; Fiskum, G.; Fahy, B.; Darwish, R.; Aarabi, B.; Yuan, J.; Moskowitz, M.A. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J. Neurosci., 2002, 22, 3504-3511.
11. Chou, J.J.; Matsuo, H.; Duan, H.; Wagner, G. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell, 1998, 94, 171-180.
12. Chou, K.C.; Jones, D.; Heinrikson, R.L. Prediction of the tertiary structure and substrate binding site of caspase-8. FEBS Lett., 1997, 419, 49-54.
13. Chou, K.C.; Tomasselli, A.G.; Heinrikson, R.L. Prediction of the Tertiary Structure of a Caspase-9/Inhibitor Complex. FEBS Lett., 2000, 470, 249-256.
14. Shimizu, S.; Konishi, A.; Kodama, T.; Tsujimoto, Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. U.S.A., 2000, 97 (7), 3100-3105.
15. Susin, S.A.; Lorenzo, H.K.; Zamzami, N.; Marzo, I.; Snow, B.E.; Brothers, G.M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M.; Larochette, N.; Goodlett, D.R.; Aebersold, R.; Siderovski, D.P.; Penninger, J.M.; Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 1999, 397, 441-446.
16. Wei, M.C.; Zong, W.X.; Cheng, E.H.; Lindsten, T.; Panoutsa-kopoulou, V.; Ross, A.J.; Roth, K.A.; MacGregor, G.R.; Thompson, C.B.; Korsmeyer, S.J. Proapoptotic BAX and BAK. a requisite gateway to mitochondrial dysfunction and death. Science, 2001, 292, 727-730.
17. Chou, J.J.; Li, H.; Salvessen, G.S.; Yuan, J.; Wagner, G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell, 1999, 96, 615-624.
18. Shen, Y.C.; Shiao, Y.J.; Sung, Y.J.; Wang, C.N. Pathogenesis Of Neurodegenerative Diseases And The Effect Of Natural Products On Nitric Oxide Production Implicating In These Diseases. J. Chin. Med., 2005, 16(2-3), 63-87.
19. Brocklehurst, K.J.; Payne, V.A.; Davies, R.A.; Carroll, D.; Vertigan, H.L.; Wightman, H.J.; Aiston, S.; Waddell, I.D.; Leighton, B.; Coghlan, M.P.; Agius, L. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators. Diabetes, 2004, 53(3), 535-41.
20. Petros, A.M.; Olejniczak, E.T.; Fesik S.W. Structural biology of the Bcl-2 family of proteins. Biochim. Biophy. Acta, 2004, 1644, 83-94.
21. Chou, K.C. Review: Structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004, 11, 2105-2134.
22. Chou, K.C.; Shen, H.B. Cell-PLoc: A package of web-servers for predicting subcellular localization of proteins in various organisms. Nature Protocols, 2008, 3, 153-162.
23. Chou, K.C.; Shen, H.B. Review: Recent progresses in protein subcellular location prediction. Anal. Biochem., 2007, 370, 1-16.
24. Chou, K.C.; Shen, H.B. MemType-2L: A Web server for predicting membrane proteins and their types by incorporating evolution information through Pse-PSSM. Biochem. Biophys. Res. Comm., 2007, 360, 339-345.
25. Shen, H.B.; Chou, K.C. EzyPred: A top-down approach for predicting enzyme functional classes and subclasses. Biochem. Biophys. Res. Comm., 2007, 364, 53-59.
26. Chou, K.C.; Shen, H.B. ProtIdent: A web server for identifying proteases and their types by fusing functional domain and sequential evolution information. Biochem. Biophys. Res. Comm., 2008, 376, 321-325.
27. Shen, H.B.; Chou, K.C. Identification of proteases and their types. Anal. Biochem., 2009, 385, 153-160.
28. Chou, K.C. A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. J. Biol. Chem., 1993, 268, 16938-16948.
29. Chou, K.C. Review: Prediction of HIV protease cleavage sites in proteins. Anal. Biochem., 1996, 233, 1-14.
30. Shen, H.B.; Chou, K.C. HIVcleave: a web-server for predicting HIV protease cleavage sites in proteins. Anal. Biochem., 2008, 375, 388-390.
31. Chou, K.C.; Shen, H.B. Signal-CF: a subsite-coupled and window-fusing approach for predicting signal peptides. Biochem. Biophys. Res. Comm., 2007, 357, 633-640.
32. Shen, H.B.; Chou, K.C. Signal-3L: a 3-layer approach for predicting signal peptide. Biochem. Biophys. Res. Comm., 2007, 363, 297-303.
33. Chou, K.C.; Wei, D.Q.; Zhong, W.Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Comm., 2003, 308, 148-151.
34. Chou, K.C.; Wei, D.Q.; Du, Q.S.; Sirois, S.; Zhong, W.Z. Review: Progress in computational approach to drug development against SARS. Curr. Med. Chem., 2006, 13, 3263-3270.
35. Zhou, G.P.; Troy, F.A. NMR studies on how the binding complex of polyisoprenol recognition sequence peptides and polyisoprenols can modulate membrane structure. Curr. Protein Pept. Sci., 2005, 6, 399-411.
36. Wei, H.; Zhang, R.; Wang, C.; Zheng, H.; Chou, K.C.; Wei, D.Q. Molecular insights of SAH enzyme catalysis and their implication for inhibitor design. J. Theor. Biol., 2007, 244, 692-702.
37. Du, Q.S.; Wang, S.; Wei, D.Q.; Sirois, S.; Chou, K.C. Molecular modelling and chemical modification for finding peptide inhibitor against SARS CoV Mpro. Anal. Biochem., 2005, 337, 262-270.
38. Zhang, R.; Wei, D.Q.; Du, Q.S.; Chou, K.C. Molecular modeling studies of peptide drug candidates against SARS. Med. Chem., 2006, 2, 309-314.
39. Li, L.; Wei, D.Q.; Wang, J.F.; Chou, K.C. Computational studies of the binding mechanism of calmodulin with chrysin. Biochem. Bio-phys. Res. Comm., 2007, 358, 1102-1107.
40. Wang, J.F.; Wei, D.Q.; Chen, C.; Li, Y.; Chou, K.C. Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design. Protein Pept. Lett., 2008, 15, 27-32.
41. Johnson, M.S.; Srinivasan, N.; Sowdhamini, R.; Blundell, T.L. Knowledge-Based Protein Modeling. Biochem. Mol. Biol., 1994, 29, 1-68.
42. Yang, J.; Liu, C.Q. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120. Acta Pharmacol. Sin., 2000, 21, 29-34.
43. Yang, J.; Zhan, C.Y.; Dong, X.C.; Yang, K.; Wang, F.X. Interaction of Human Fibrinogen Receptor (GPIIb-IIIa) with Decorsin. Acta Pharmacol. Sin., 2004, 25(8), 1096-1104.
44. Zhan, C.Y.; Yang, J.; Dong, X.C.; Wang, Y.L. Molecular Modeling of Purinergic Receptor P2Y12 and Interaction with its antagonists. J. Mol. Graph. Model., 2007, 26, 20-31.
45. Yang, J. Molecular modeling of human BAD and its interaction with PKAc or PP1c. J. Theor. Biol., 2009, 257, 159-169.
46. McDonnell, J.M.; Fushman, D.; Milliman, C.L.; Korsmeyer, S.J.; Cowburn, D. Solution Structure Of The Proapoptotic Molecule Bid: A Structural Basis For Apoptotic Agonists And Antagonists. Cell, 1999, 96, 625-634.
47. Yang, X.; Lee, W.H.; Sobott, F.; Papagrigoriou, E.; Robinson, C.V.; Grossmann, J.G.; Sundstrom, M.; Doyle, D.A.; Elkins, J.M. Structural basis for protein-protein interactions in the 14-3-3 protein family. Proc. Natl. Acad. Sci. USA, 2006, 103(46), 17237-17242.
48. Zheng, J.; Knighton, D.R.; Xuong, N.H.; Taylor, S.S.; Sowadski, J.M.; Ten Eyck, L.F. Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. Protein Sci., 1993, 2, 1559-1573.
49. Yin, X. M.; Oltvai, Z. N.; Korsmeyer, S. J. BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature, 1994, 369, 321-333.
50. Coultas, L.; Bouillet, P.; Stanley, E.G.; Brodnicki, T.C.; Adams, J.M.; Strasser, A. Proapoptotic BH3-Only Bcl-2 Family Member Bik/Blk/Nbk Is Expressed in Hemopoietic and Endothelial Cells but Is Redundant for Their Programmed Death. Mol. Cell. Biol., 2004, 24(4), 1570-1581.
51. Li, R.X.; Boehm, A.L.; Miranda, M.B.; Shangary, S.; Grandis, J.R.; Johnson, D.E. Targeting Antiapoptotic Bcl-2 Family Members with Cell-Permeable BH3 Peptides Induces Apoptosis Signaling and Death in Head and Neck Squamous Cell Carcinoma Cells. Neoplasia, 2007, 9(10), 80-811.
52. Liu, D.X.; Yang, B.; Cao, R.; Huang, Z.W.A chemical strategy to promote helical peptide-protein interactions involved in apoptosis. Bioorg. Med. Chem. Lett., 2005, 15, 4467-4469.
53. Liu, X.Q.; Dai, S.D.; Zhu, Y.N.; Marrack, P.; Kapple, J.W. The Structure of a Bcl-xL/Bim Fragment Complex: Implications for Bim Function. Immunity, 2003, 19, 341-352.
54. Malissein, E.; Verdier, M.; Ratinaud, M.H.; Troutaud, D. Changes in Bad phosphorylation are correlated with BCR-induced apoptosis of WEHI-231 immature B cells. Biochim., 2003, 85, 733-740.
55. Conklin, D.S.; Galaktionov, K.; Beach, D. 14-3-3 proteins associate with cdc25 phosphatases. Proc. Natl. Acad. Sci. U.S.A., 1995, 92(17), 7892-7896.
56. Chong, S.S.; Tanigami, A.; Roschke, A.V.; Ledbetter, D.H. 14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome region. Genome Res., 1996, 6(8), 735-741.
57. Aoki, H.; Hayashi, J.; Moriyama, M.; Arakawa, Y.; Hino, O. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J. Virol., 2001, 74(4), 1736-1741.
58. Kim, C.; Xuong, N.H.; Taylor, S.S. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA. Science, 2005, 307(5710), 690-696.
59. Strausberg, R.L.; Feingold, E.A.; Grouse, L.H.; Derge, J.G.; Klausner, R.D.; Collins, F.S.; Wagner, L.; Shenmen, C.M.; Schuler, G.D., Altschul, S.F.; Zeeberg, B.; Buetow, K.H.; Schaefer, C.F.; Bhat, N.K.; Hopkins, R.F.; Jordan, H.; Moore, T.; Max, S.I.; Wang, J.; Marra, M.A. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA, 2002, 99, 16899-16903.